Faraz Ali - Net Worth and Insider Trading

Faraz Ali Net Worth

The estimated net worth of Faraz Ali is at least $529,210 dollars as of 2024-05-04. Faraz Ali is the CEO of Tenaya Therapeutics Inc and owns about 113,079 shares of Tenaya Therapeutics Inc (TNYA) stock worth over $529,210. Details can be seen in Faraz Ali's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Faraz Ali has not made any transactions after 2024-02-16 and currently still holds the listed stock(s).

Transaction Summary of Faraz Ali

To

Faraz Ali Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Faraz Ali owns 2 companies in total, including Regenxbio Inc (RGNX) , and Tenaya Therapeutics Inc (TNYA) .

Click here to see the complete history of Faraz Ali’s form 4 insider trades.

Insider Ownership Summary of Faraz Ali

Ticker Comapny Transaction Date Type of Owner
RGNX Regenxbio Inc 2016-02-29 Chief Business Officer
TNYA Tenaya Therapeutics Inc 2024-02-16 director & Chief Executive Officer

Faraz Ali Latest Holdings Summary

Faraz Ali currently owns a total of 1 stock. Faraz Ali owns 113,079 shares of Tenaya Therapeutics Inc (TNYA) as of February 16, 2024, with a value of $529,210.

Latest Holdings of Faraz Ali

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TNYA Tenaya Therapeutics Inc 2024-02-16 113,079 4.68 529,210

Holding Weightings of Faraz Ali


Faraz Ali Form 4 Trading Tracker

According to the SEC Form 4 filings, Faraz Ali has made a total of 2 transactions in Tenaya Therapeutics Inc (TNYA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Tenaya Therapeutics Inc is the sale of 6,358 shares on February 16, 2024, which brought Faraz Ali around $37,258.

Insider Trading History of Faraz Ali

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Faraz Ali Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Faraz Ali Ownership Network

Ownership Network List of Faraz Ali

No Data

Ownership Network Relation of Faraz Ali


Faraz Ali Owned Company Details

What does Regenxbio Inc do?

Who are the key executives at Regenxbio Inc?

Faraz Ali is the Chief Business Officer of Regenxbio Inc. Other key executives at Regenxbio Inc include director & See Remarks Kenneth T. Mills , Chief Medical Officer Steve Pakola , and See Remarks Vittal Vasista .

Regenxbio Inc (RGNX) Insider Trades Summary

Over the past 18 months, Faraz Ali made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 135,000 shares made by Kenneth T. Mills , and a net sale of 12,878 shares made by Steve Pakola .

In summary, during the past 3 months, insiders sold 57,878 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 57,878 shares. During the past 18 months, 147,878 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 147,878 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regenxbio Inc Insider Transactions

No Available Data

Faraz Ali Mailing Address

Above is the net worth, insider trading, and ownership report for Faraz Ali. You might contact Faraz Ali via mailing address: C/o Tenaya Therapeutics, Inc., 171 Oyster Point Blvd., 5th Flr., South San Francisco Z4 94080.

Discussions on Faraz Ali

No discussions yet.